Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors
暂无分享,去创建一个
A. Llombart‐Bosch | S. Knuutila | L. Andersson | J. López-Guerrero | J. Lasota | M. Miettinen | M. Sarlomo‐Rikala | R. Ässämäki | A. Llombart-Bosch
[1] J. Vermeesch,et al. Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status , 2007, Genes, chromosomes & cancer.
[2] J. Lasota,et al. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. , 2009, Archives of pathology & laboratory medicine.
[3] Stine H. Kresse,et al. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. , 2006, Cancer research.
[4] J. Stachura,et al. GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology , 2006, Laboratory Investigation.
[5] Florian Haller,et al. Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors , 2005, Clinical Cancer Research.
[6] Arie Perry,et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. , 2005, Cancer research.
[7] M. Pierotti,et al. 9p21 locus analysis in high‐risk gastrointestinal stromal tumors characterized for c‐kit and platelet‐derived growth factor receptor α gene alterations , 2005, Cancer.
[8] J. Ko,et al. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor‐suppressive regions to 14q32 , 2005, Genes, chromosomes & cancer.
[9] M. Debiec‐Rychter,et al. KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs). , 2005, Biochimica et biophysica acta.
[10] P. Marynen,et al. Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. , 2005, Gastroenterology.
[11] S. Knuutila,et al. Gene amplifications in osteosarcoma—CGH microarray analysis , 2005, Genes, chromosomes & cancer.
[12] A. Hartmann,et al. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] E. Musulen,et al. Gastrointestinal stromal tumors , 2006, Abdominal Imaging.
[14] Chung-Liang Ho,et al. Allelic loss of 14q32 in the pathogenesis of gastrointestinal and ampullary malignancies: mapping of the target region to a 17 cM interval , 2005, Journal of Cancer Research and Clinical Oncology.
[15] Elena Marchiori,et al. Breakpoint identification and smoothing of array comparative genomic hybridization data , 2004, Bioinform..
[16] Yanchun Deng,et al. NDRG2 expression and mutation in human liver and pancreatic cancers. , 2004, World journal of gastroenterology.
[17] E. Kay,et al. Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors , 2004, Modern Pathology.
[18] Patrick G Buckley,et al. Genomic microarrays in the spotlight. , 2004, Trends in genetics : TIG.
[19] L. Larocca,et al. Role of p16/INK4a in gastrointestinal stromal tumor progression. , 2004, American journal of clinical pathology.
[20] C. Tzeng,et al. Biological significance of chromosomal imbalance aberrations in gastrointestinal stromal tumors. , 2004, Journal of biomedical science.
[21] S. Leung,et al. N‐Myc downstream‐regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation , 2003, International journal of cancer.
[22] Samuel Singer,et al. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.
[23] G. Enders. The INK4a/ARF locus and human cancer. , 2003, Methods in molecular biology.
[24] B. Gunawan,et al. Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. , 2002, Human pathology.
[25] Michael Baudis,et al. Progenetix.net: an online repository for molecular cytogenetic aberration data , 2001, Bioinform..
[26] P. D. Dal Cin,et al. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors , 2001, Genes, chromosomes & cancer.
[27] M. Debiec‐Rychter,et al. Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. , 2001, Cancer genetics and cytogenetics.
[28] L. Sobin,et al. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. , 2000, The American journal of pathology.
[29] L. Kindblom,et al. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). , 2000, Cancer genetics and cytogenetics.
[30] S. Knuutila,et al. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. , 2000, Cancer research.
[31] R. Passantino,et al. ENO1 gene product binds to the c‐myc promoter and acts as a transcriptional repressor: relationship with Myc promoter‐binding protein 1 (MBP‐1) , 2000, FEBS letters.
[32] E. de Álava,et al. Predicting Metastatic Risk of Gastrointestinal Stromal Tumors: Role of Cell Proliferation and Cell Cycle Regulatory Proteins , 2000, International journal of surgical pathology.
[33] S. Knuutila,et al. High‐resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci , 2000, Genes, chromosomes & cancer.
[34] J. Fletcher,et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. , 2000, The American journal of pathology.
[35] H. Kondoh,et al. Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. , 1999, Biochemical and biophysical research communications.
[36] L. Sobin,et al. Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[37] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[38] M. Johansson. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues. , 1999, Genomics.
[39] R. Hruban,et al. High‐resolution deletion mapping of chromosome arm 1p in pancreatic cancer identifies a major consensus region at 1p35 , 1999, Genes, chromosomes & cancer.
[40] S. Knuutila,et al. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. , 1998, Human pathology.
[41] S. Knuutila,et al. Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity. , 1998, Cancer genetics and cytogenetics.
[42] Z. Ao,et al. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Knuutila,et al. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. , 1996, Cancer research.
[44] Gregory J. Hannon,et al. pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.
[45] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[46] G. Hannon,et al. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. , 1994, Nature.
[47] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[48] C. Robson,et al. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. , 1991, Nucleic acids research.